Mirum Pharmaceuticals (MIRM) EPS (Basic) (2019 - 2026)
Mirum Pharmaceuticals' (MIRM) quarterly EPS (Basic) came in at -$13.43 in Q1 2026, down 4372.32% year-on-year from $0.31 in Q1 2025, and down 11662.31% quarter-over-quarter from -$0.11 in Q4 2025.
Mirum Pharmaceuticals (MIRM) EPS (Basic) (2019 - 2026) Analysis & Trends
Mirum Pharmaceuticals' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$13.43 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 4372.32% year-over-year to -$13.43 in Q1 2026; TTM through Mar 2026 was -$13.57, a 758.05% decrease from a year earlier, with the FY2025 full-year figure at -$0.47, up 74.85% from the prior year.
- EPS (Basic) retreated to -$13.43 in Q1 2026 per MIRM's latest filing, from -$0.11 in the prior quarter.
- Across five years, EPS (Basic) topped out at $0.06 in Q3 2025 and bottomed at -$13.43 in Q1 2026.
- The 5-year median for EPS (Basic) is -$0.57 (2023), against an average of -$1.41.
- Across the five-year window, EPS (Basic) surged 119.26% in 2025 and plunged 4372.32% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$1.08 in 2022, then gained by 18.99% to -$0.87 in 2023, then surged by 42.6% to -$0.5 in 2024, then surged by 77.2% to -$0.11 in 2025, then plunged by 11662.31% to -$13.43 in 2026.
- Per Business Quant, the three latest MIRM EPS (Basic) figures stand at -$13.43 (Q1 2026), -$0.11 (Q4 2025), and $0.06 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Mirum Pharmaceuticals | 6.66 Bn | 6.27 Bn | 131.08 Mn | -13.43 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.43 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | 0.06 |
| Jun 30, 2025 | -0.12 |
| Mar 31, 2025 | -0.30 |
| Dec 31, 2024 | -0.50 |
| Sep 30, 2024 | -0.30 |
| Jun 30, 2024 | -0.52 |
| Mar 31, 2024 | -0.54 |
| Dec 31, 2023 | -0.87 |
| Sep 30, 2023 | -0.57 |
| Jun 30, 2023 | -1.94 |
| Mar 31, 2023 | -0.80 |
| Dec 31, 2022 | -1.08 |
| Sep 30, 2022 | -1.02 |
| Jun 30, 2022 | -0.84 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | 1.89 |
| Sep 30, 2021 | -1.55 |
| Jun 30, 2021 | -1.45 |